remifentanil has been researched along with Infant, Newborn, Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harnischmacher, U; Junghaenel, S; Link, F; Oberthuer, A; Roth, B; Stuetzer, H; Welzing, L | 1 |
| Amison, N; Avidan, A; Eventov-Friedman, S; Ginosar, Y; Shaylor, R; Weiniger, CF | 1 |
1 trial(s) available for remifentanil and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Remifentanil-induced tolerance, withdrawal or hyperalgesia in infants: a randomized controlled trial. RAPIP trial: remifentanil-based analgesia and sedation of paediatric intensive care patients.
Topics: Analgesia; Analgesics, Opioid; Drug Tolerance; Fentanyl; Gestational Age; Humans; Hyperalgesia; Hypnotics and Sedatives; Infant; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Intensive Care Units, Pediatric; Piperidines; Remifentanil; Respiration, Artificial; Substance Withdrawal Syndrome | 2013 |
1 other study(ies) available for remifentanil and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Pre-delivery remifentanil infusion for placenta accreta cesarean delivery under general anesthesia: an observational study.
Topics: Adult; Analgesics, Opioid; Apgar Score; Cesarean Section; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Piperidines; Placenta Accreta; Pregnancy; Prospective Studies; Remifentanil | 2016 |